MicroRNA-33 protects against neointimal hyperplasia induced by arterial mechanical stretch in the grafted vein

Cardiovasc Res. 2017 Apr 1;113(5):488-497. doi: 10.1093/cvr/cvw257.

Abstract

Aims: Mechanical factors play significant roles in neointimal hyperplasia after vein grafting, but the mechanisms are not fully understood. Here, we investigated the roles of microRNA-33 (miR-33) in neointimal hyperplasia induced by arterial mechanical stretch after vein grafting.

Methods and results: Grafted veins were generated by the 'cuff' technique. Neointimal hyperplasia and cell proliferation was significantly increased, and miR-33 expression was decreased after 1-, 2-, and 4-week grafts. In contrast, the expression of bone morphogenetic protein 3 (BMP3), which is a putative target of miR-33, and the phosphorylation of smad2 and smad5, which are potential downstream targets of BMP3, were increased in the grafted veins. miR-33 mimics/inhibitor and dual luciferase reporter assay confirmed the interaction of miR-33 and BMP3. miR-33 mimics attenuated, while miR-33 inhibitor accelerated, proliferation of venous smooth muscle cells (SMCs). Moreover, recombinant BMP3 increased SMC proliferation and P-smad2 and P-smad5 levels, whereas BMP3-directed siRNAs had the opposite effect. Then, venous SMCs were exposed to a 10%-1.25 Hz cyclic stretch (arterial stretch) by using the FX4000 cyclic stretch loading system in vitro to mimic arterial mechanical conditions. The arterial stretch increased venous SMC proliferation and repressed miR-33 expression, but enhanced BMP3 expression and smad2 and smad5 phosphorylation. Furthermore, perivascular multi-point injection in vivo demonstrated that agomiR-33 not only attenuates BMP3 expression and smad2 and smad5 phosphorylation, but also slows neointimal formation and cell proliferation in grafted veins. These effects of agomiR-33 on grafted veins could be reversed by local injection of BMP3 lentivirus.

Conclusion: The miR-33-BMP3-smad signalling pathway protects against venous SMC proliferation in response to the arterial stretch. miR-33 is a target that attenuates neointimal hyperplasia in grafted vessels and may have potential clinical applications.

Keywords: Mechanical stretch; MicroRNAs; Neointimal hyperplasia; Smooth muscle cells; Vein graft.

MeSH terms

  • 3' Untranslated Regions
  • Animals
  • Antagomirs / genetics
  • Antagomirs / metabolism
  • Binding Sites
  • Bone Morphogenetic Protein 3 / genetics
  • Bone Morphogenetic Protein 3 / metabolism
  • Cell Proliferation*
  • Cells, Cultured
  • Hyperplasia
  • Jugular Veins / metabolism*
  • Jugular Veins / pathology
  • Jugular Veins / transplantation*
  • Male
  • Mechanotransduction, Cellular*
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Muscle, Smooth, Vascular / metabolism
  • Muscle, Smooth, Vascular / pathology
  • Muscle, Smooth, Vascular / transplantation
  • Myocytes, Smooth Muscle / metabolism
  • Myocytes, Smooth Muscle / pathology
  • Myocytes, Smooth Muscle / transplantation
  • Neointima*
  • Phosphorylation
  • RNA Interference
  • Rats, Sprague-Dawley
  • Smad2 Protein / metabolism
  • Smad5 Protein / metabolism
  • Stress, Mechanical
  • Time Factors
  • Transfection

Substances

  • 3' Untranslated Regions
  • Antagomirs
  • Bmp3 protein, rat
  • Bone Morphogenetic Protein 3
  • MIRN33 microRNA, rat
  • MicroRNAs
  • Smad2 Protein
  • Smad2 protein, rat
  • Smad5 Protein
  • Smad5 protein, rat